We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$59.6B
AUM Growth
+$306M
Cap. Flow
+$3.25B
Cap. Flow %
5.45%
Top 10 Hldgs %
34.29%
Holding
910
New
50
Increased
586
Reduced
175
Closed
66

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.14B
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$96.9M
3
NVDA icon
NVIDIA
NVDA
+$86.8M
4
MSFT icon
Microsoft
MSFT
+$86.3M
5
KO icon
Coca-Cola
KO
+$75M

Top Sells

Rank Stock Value
1
D icon
Dominion Energy
D
+$90.4M
2
CRH icon
CRH
CRH
+$79.8M
3
MCO icon
Moody's
MCO
+$63.3M
4
PG icon
Procter & Gamble
PG
+$61.9M
5
TSM icon
TSMC
TSM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 30.72%
2 Financials 12.76%
3 Healthcare 12.55%
4 Communication Services 9.75%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEM icon
101
Newmont
NEM
$96B
$113M 0.19%
1,041,852
+26,694
+3% +$3.08M
WELL icon
102
Welltower
WELL
$172B
$112M 0.19%
566,969
+18,149
+3% +$3.59M
ENB icon
103
Enbridge
ENB
$122B
$112M 0.19%
2,064,211
+59,576
+3% +$3.03M
MDLZ icon
104
Mondelez International
MDLZ
$77B
$109M 0.18%
1,890,756
+54,200
+3% +$3.14M
KMI icon
105
Kinder Morgan
KMI
$72.8B
$109M 0.18%
3,237,095
+83,010
+3% +$2.59M
MCK icon
106
McKesson
MCK
$97.8B
$108M 0.18%
124,983
+64
+0.1% +$57.1K
SRE icon
107
Sempra
SRE
$59.5B
$108M 0.18%
1,106,615
+21,129
+2% +$1.93M
BMY icon
108
Bristol-Myers Squibb
BMY
$124B
$107M 0.18%
1,767,159
+51,415
+3% +$3M
TT icon
109
Trane Technologies
TT
$103B
$106M 0.18%
254,202
+6,906
+3% +$2.93M
INTU icon
110
Intuit
INTU
$80.6B
$106M 0.18%
244,420
+6,795
+3% +$3.24M
COF icon
111
Capital One
COF
$128B
$105M 0.18%
576,361
+16,245
+3% +$3.4M
PGR icon
112
Progressive
PGR
$122B
$102M 0.17%
513,363
+14,513
+3% +$3M
CB icon
113
Chubb
CB
$137B
$101M 0.17%
308,715
-7,609
-2% -$2.44M
AON icon
114
Aon
AON
$77.8B
$100M 0.17%
310,335
-23,119
-7% -$7.68M
PH icon
115
Parker-Hannifin
PH
$119B
$99.4M 0.17%
111,077
+3,156
+3% +$2.99M
VRTX icon
116
Vertex Pharmaceuticals
VRTX
$123B
$99.3M 0.17%
222,452
+6,241
+3% +$2.91M
MELI icon
117
Mercado Libre
MELI
$93.5B
$97.1M 0.16%
56,186
-8,818
-14% -$17M
SYK icon
118
Stryker
SYK
$123B
$97.1M 0.16%
295,398
+8,450
+3% +$3.03M
CEG icon
119
Constellation Energy
CEG
$90.8B
$95.5M 0.16%
342,065
+6,948
+2% +$2.11M
CMCSA icon
120
Comcast
CMCSA
$85.2B
$95.4M 0.16%
3,321,827
+94,715
+3% +$2.83M
PANW icon
121
Palo Alto Networks
PANW
$294B
$94.7M 0.16%
590,791
+21,987
+4% +$3.69M
MDT icon
122
Medtronic
MDT
$107B
$93.7M 0.16%
1,081,074
+30,792
+3% +$2.95M
BSX icon
123
Boston Scientific
BSX
$65.7B
$93.4M 0.16%
1,488,608
+2,896
+0.2% +$232K
GLW icon
124
Corning
GLW
$133B
$93.3M 0.16%
686,174
+20,083
+3% +$2.42M
HLT icon
125
Hilton Worldwide
HLT
$73.2B
$92.6M 0.16%
304,467
-55,786
-15% -$16.9M

Similar funds

Aviva's Q1 2026 Portfolio in Review

As of Q1 2026, Aviva held 910 positions worth $59.6B, up 0.52% from $59.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Aviva deployed $3.25B of net new capital in Q1 2026, opening 50 new positions and adding to 586 existing holdings. Its largest new stake was AstraZeneca: 11,087,661 shares worth $2.15B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dominion Energy, an estimated $90.4M trimmed.

  • Aviva's largest Q1 2026 buy was AstraZeneca: 11,087,661 shares worth $2.15B.
  • Aviva added most to NVIDIA in Q1 2026, an estimated $86.8M increase.
  • Aviva's biggest Q1 2026 reduction was Dominion Energy, cutting an estimated $90.4M.
  • Aviva fully exited Alibaba in Q1 2026, selling an estimated $51M.
  • Aviva's ten largest holdings make up 34% of its $59.6B portfolio in Q1 2026.
  • Aviva opened 50 new positions and closed 66 in Q1 2026.
  • Aviva's portfolio value rose 0.52% quarter-over-quarter to $59.6B.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.